Clearstead Advisors, LLC Lucid Diagnostics Inc. Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 1 shares of LUCD stock, worth $1. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$1% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LUCD
# of Institutions
78Shares Held
19.5MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.52MShares$4.8 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA2.73MShares$2.89 Million0.13% of portfolio
-
Abrdn PLC2.5MShares$2.65 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.67MShares$1.77 Million0.0% of portfolio
-
Perkins Capital Management Inc1.13MShares$1.19 Million1.13% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $40.9M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...